PREPROPOSAL STATEMENT OF INQUIRY
HEALTH CARE AUTHORITY
[Filed January 10, 2020, 4:11 p.m.]
Subject of Possible Rule Making: New chapter 182-51 WAC, Washington prescription drug price transparency program.
Statutes Authorizing the Agency to Adopt Rules on this Subject: RCW 41.05.021
, and ESSHB [E2SHB] 1224, chapter 334, Laws of 2019.
Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: To implement the Washington prescription drug price transparency program as required under chapter 43.71C
Other Federal and State Agencies that Regulate this Subject and the Process Coordinating the Rule with These Agencies: Not applicable.
Process for Developing New Rule: The agency welcomes the public to take part in developing this rule. If interested, contact the person identified below to receive an early rule draft to review. After the early review, the agency will send a notice of proposed rule making (CR-102) to everyone receiving this notice and anyone who requests a copy.
Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Jason Crabbe (Rule Writer), P.O. Box 42716, Olympia, WA 98504-2716, phone 360-725-9563, fax 360-586-9727, telecommunication relay services (TRS) 711, email firstname.lastname@example.org, website www.hca.wa.gov/about-hca/rulemaking; or Annette Schuffenhauer (Program Questions), P.O. Box 42716, Olympia, WA 98504-2716, phone 360-725-1254, fax 360-586-9727, TRS 711, email email@example.com, website www.hca.wa.gov/about-hca/rulemaking.
January 10, 2020